-
1
-
-
84863264554
-
Cancer and radiation therapy: current advances and future directions
-
Baskar, R., Lee, K.A., Yeo, R., Yeoh, K.-W., Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 9 (2012), 193–199.
-
(2012)
Int. J. Med. Sci.
, vol.9
, pp. 193-199
-
-
Baskar, R.1
Lee, K.A.2
Yeo, R.3
Yeoh, K.-W.4
-
2
-
-
32944481156
-
An essential role of antigen-presenting cell/T-helper type 1 cell–cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy
-
Chamoto, K., Wakita, D., Narita, Y., Zhang, Y., Noguchi, D., Ohnishi, H., Iguchi, T., Sakai, T., Ikeda, H., Nishimura, T., An essential role of antigen-presenting cell/T-helper type 1 cell–cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Cancer Res. 66 (2006), 1809–1817.
-
(2006)
Cancer Res.
, vol.66
, pp. 1809-1817
-
-
Chamoto, K.1
Wakita, D.2
Narita, Y.3
Zhang, Y.4
Noguchi, D.5
Ohnishi, H.6
Iguchi, T.7
Sakai, T.8
Ikeda, H.9
Nishimura, T.10
-
3
-
-
42949098879
-
Death by a thousand cuts: granzyme pathways of programmed cell death
-
Chowdhury, D., Lieberman, J., Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26 (2008), 389–420.
-
(2008)
Annu. Rev. Immunol.
, vol.26
, pp. 389-420
-
-
Chowdhury, D.1
Lieberman, J.2
-
4
-
-
84873527068
-
The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer
-
Christiansen, A., Dyrskjøt, L., The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer. Cancer Lett. 331 (2013), 18–23.
-
(2013)
Cancer Lett.
, vol.331
, pp. 18-23
-
-
Christiansen, A.1
Dyrskjøt, L.2
-
5
-
-
33746038130
-
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer
-
Dahl, E., Kristiansen, G., Gottlob, K., Klaman, I., Ebner, E., Hinzmann, B., Hermann, K., Pilarsky, C., Dürst, M., Klinkhammer-Schalke, M., Blaszyk, H., Knuechel, R., Hartmann, A., Rosenthal, A., Wild, P.J., Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clin. Cancer Res. 12 (2006), 3950–3960.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 3950-3960
-
-
Dahl, E.1
Kristiansen, G.2
Gottlob, K.3
Klaman, I.4
Ebner, E.5
Hinzmann, B.6
Hermann, K.7
Pilarsky, C.8
Dürst, M.9
Klinkhammer-Schalke, M.10
Blaszyk, H.11
Knuechel, R.12
Hartmann, A.13
Rosenthal, A.14
Wild, P.J.15
-
6
-
-
84883785740
-
Inducers of immunogenic cancer cell death
-
Dudek, A.M., Garg, A.D., Krysko, D.V., De Ruysscher, D., Agostinis, P., Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev. 24 (2013), 319–333.
-
(2013)
Cytokine Growth Factor Rev.
, vol.24
, pp. 319-333
-
-
Dudek, A.M.1
Garg, A.D.2
Krysko, D.V.3
De Ruysscher, D.4
Agostinis, P.5
-
7
-
-
77954641944
-
Radiation-induced cell death mechanisms
-
Eriksson, D., Stigbrand, T., Radiation-induced cell death mechanisms. Tumour Biol. 31 (2010), 363–372.
-
(2010)
Tumour Biol.
, vol.31
, pp. 363-372
-
-
Eriksson, D.1
Stigbrand, T.2
-
8
-
-
84896724517
-
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
-
Gameiro, S.R., Jammeh, M.L., Wattenberg, M.M., Tsang, K.Y., Ferrone, S., Hodge, J.W., Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget 5 (2014), 403–416.
-
(2014)
Oncotarget
, vol.5
, pp. 403-416
-
-
Gameiro, S.R.1
Jammeh, M.L.2
Wattenberg, M.M.3
Tsang, K.Y.4
Ferrone, S.5
Hodge, J.W.6
-
9
-
-
84874418442
-
The convergence of radiation and immunogenic cell death signaling pathways
-
Golden, E.B., Pellicciotta, I., Demaria, S., Barcellos-Hoff, M.H., Formenti, S.C., The convergence of radiation and immunogenic cell death signaling pathways. Front. Oncol., 2, 2012.
-
(2012)
Front. Oncol.
, vol.2
-
-
Golden, E.B.1
Pellicciotta, I.2
Demaria, S.3
Barcellos-Hoff, M.H.4
Formenti, S.C.5
-
10
-
-
84908556568
-
KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas
-
Gousias, K., Niehusmann, P., Gielen, G., Simon, M., Boström, J., KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas. J. Clin. Neurosci. 21 (2014), 1719–1724.
-
(2014)
J. Clin. Neurosci.
, vol.21
, pp. 1719-1724
-
-
Gousias, K.1
Niehusmann, P.2
Gielen, G.3
Simon, M.4
Boström, J.5
-
11
-
-
67349124914
-
Immunogenic and tolerogenic cell death
-
Green, D.R., Ferguson, T., Zitvogel, L., Kroemer, G., Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9 (2009), 353–363.
-
(2009)
Nat. Rev. Immunol.
, vol.9
, pp. 353-363
-
-
Green, D.R.1
Ferguson, T.2
Zitvogel, L.3
Kroemer, G.4
-
12
-
-
84891736053
-
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
-
Grupp, K., Habermann, M., Sirma, H., Simon, R., Steurer, S., Hube-Magg, C., Prien, K., Burkhardt, L., Jedrzejewska, K., Salomon, G., Heinzer, H., Wilczak, W., Kluth, M., Izbicki, J.R., Sauter, G., Minner, S., Schlomm, T., Tsourlakis, M.C., High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy. Mod. Pathol. 27 (2014), 96–106.
-
(2014)
Mod. Pathol.
, vol.27
, pp. 96-106
-
-
Grupp, K.1
Habermann, M.2
Sirma, H.3
Simon, R.4
Steurer, S.5
Hube-Magg, C.6
Prien, K.7
Burkhardt, L.8
Jedrzejewska, K.9
Salomon, G.10
Heinzer, H.11
Wilczak, W.12
Kluth, M.13
Izbicki, J.R.14
Sauter, G.15
Minner, S.16
Schlomm, T.17
Tsourlakis, M.C.18
-
13
-
-
84906567126
-
Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma
-
Hu, Z.-Y., Yuan, S.-X., Yang, Y., Zhou, W.-P., Jiang, H., Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma. J. Exp. Clin. Cancer Res., 33, 2014, 61.
-
(2014)
J. Exp. Clin. Cancer Res.
, vol.33
, pp. 61
-
-
Hu, Z.-Y.1
Yuan, S.-X.2
Yang, Y.3
Zhou, W.-P.4
Jiang, H.5
-
14
-
-
84882569092
-
KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a
-
Huang, L., Wang, H.-Y., Li, J.-D., Wang, J.-H., Zhou, Y., Luo, R.-Z., Yun, J.-P., Zhang, Y., Jia, W.-H., Zheng, M., KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Cell Death Dis., 4, 2013, e745.
-
(2013)
Cell Death Dis.
, vol.4
, pp. e745
-
-
Huang, L.1
Wang, H.-Y.2
Li, J.-D.3
Wang, J.-H.4
Zhou, Y.5
Luo, R.-Z.6
Yun, J.-P.7
Zhang, Y.8
Jia, W.-H.9
Zheng, M.10
-
15
-
-
84907958839
-
KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation
-
Ikenberg, K., Valtcheva, N., Brandt, S., Zhong, Q., Wong, C.E., Noske, A., Rechsteiner, M., Rueschoff, J.H., Caduff, R., Dellas, A., Obermann, E., Fink, D., Fuchs, T., Krek, W., Moch, H., Frew, I.J., Wild, P.J., KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. J. Pathol. 234 (2014), 239–252.
-
(2014)
J. Pathol.
, vol.234
, pp. 239-252
-
-
Ikenberg, K.1
Valtcheva, N.2
Brandt, S.3
Zhong, Q.4
Wong, C.E.5
Noske, A.6
Rechsteiner, M.7
Rueschoff, J.H.8
Caduff, R.9
Dellas, A.10
Obermann, E.11
Fink, D.12
Fuchs, T.13
Krek, W.14
Moch, H.15
Frew, I.J.16
Wild, P.J.17
-
16
-
-
79953233320
-
High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy
-
Jensen, J.B., Munksgaard, P.P., Sørensen, C.M., Fristrup, N., Birkenkamp-Demtroder, K., Ulhøi, B.P., Jensen, K.M.-E., Ørntoft, T.F., Dyrskjøt, L., High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy. Eur. Urol. 59 (2011), 841–848.
-
(2011)
Eur. Urol.
, vol.59
, pp. 841-848
-
-
Jensen, J.B.1
Munksgaard, P.P.2
Sørensen, C.M.3
Fristrup, N.4
Birkenkamp-Demtroder, K.5
Ulhøi, B.P.6
Jensen, K.M.-E.7
Ørntoft, T.F.8
Dyrskjøt, L.9
-
17
-
-
79960087865
-
Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2
-
Karlsen, M., Hovden, A.-O., Vogelsang, P., Tysnes, B.B., Appel, S., Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2. Scand. J. Immunol. 74 (2011), 135–143.
-
(2011)
Scand. J. Immunol.
, vol.74
, pp. 135-143
-
-
Karlsen, M.1
Hovden, A.-O.2
Vogelsang, P.3
Tysnes, B.B.4
Appel, S.5
-
18
-
-
85027948935
-
Quantitative proteomic analysis of single or fractionated radiation-induced proteins in human breast cancer MDA-MB-231 cells
-
Kim, M.-H., Jung, S.-Y., Ahn, J., Hwang, S.-G., Woo, H.-J., An, S., Nam, S.Y., Lim, D.-S., Song, J.-Y., Quantitative proteomic analysis of single or fractionated radiation-induced proteins in human breast cancer MDA-MB-231 cells. Cell Biosci., 5, 2015, 2.
-
(2015)
Cell Biosci.
, vol.5
, pp. 2
-
-
Kim, M.-H.1
Jung, S.-Y.2
Ahn, J.3
Hwang, S.-G.4
Woo, H.-J.5
An, S.6
Nam, S.Y.7
Lim, D.-S.8
Song, J.-Y.9
-
19
-
-
84870239310
-
Immunogenic cell death and DAMPs in cancer therapy
-
Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P., Vandenabeele, P., Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12 (2012), 860–875.
-
(2012)
Nat. Rev. Cancer
, vol.12
, pp. 860-875
-
-
Krysko, D.V.1
Garg, A.D.2
Kaczmarek, A.3
Krysko, O.4
Agostinis, P.5
Vandenabeele, P.6
-
20
-
-
84923068568
-
KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation
-
Ma, S., Zhao, X., KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation. Oncol. Rep. 32 (2014), 1631–1637.
-
(2014)
Oncol. Rep.
, vol.32
, pp. 1631-1637
-
-
Ma, S.1
Zhao, X.2
-
21
-
-
11844293451
-
Radiotherapy: what can be achieved by technical improvements in dose delivery?
-
Moran, J.M., Elshaikh, M.A., Lawrence, T.S., Radiotherapy: what can be achieved by technical improvements in dose delivery?. Lancet Oncol. 6 (2005), 51–58.
-
(2005)
Lancet Oncol.
, vol.6
, pp. 51-58
-
-
Moran, J.M.1
Elshaikh, M.A.2
Lawrence, T.S.3
-
22
-
-
79952254227
-
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy
-
Mortezavi, A., Hermanns, T., Seifert, H.-H., Baumgartner, M.K., Provenzano, M., Sulser, T., Burger, M., Montani, M., Ikenberg, K., Hofstädter, F., Hartmann, A., Jaggi, R., Moch, H., Kristiansen, G., Wild, P.J., KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin. Cancer Res. 17 (2011), 1111–1121.
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 1111-1121
-
-
Mortezavi, A.1
Hermanns, T.2
Seifert, H.-H.3
Baumgartner, M.K.4
Provenzano, M.5
Sulser, T.6
Burger, M.7
Montani, M.8
Ikenberg, K.9
Hofstädter, F.10
Hartmann, A.11
Jaggi, R.12
Moch, H.13
Kristiansen, G.14
Wild, P.J.15
-
23
-
-
84941880491
-
The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation
-
Multhoff, G., Pockley, A.G., Schmid, T.E., Schilling, D., The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation. Cancer Lett. 368 (2015), 179–184.
-
(2015)
Cancer Lett.
, vol.368
, pp. 179-184
-
-
Multhoff, G.1
Pockley, A.G.2
Schmid, T.E.3
Schilling, D.4
-
24
-
-
84859883633
-
Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro
-
Noetzel, E., Rose, M., Bornemann, J., Gajewski, M., Knüchel, R., Dahl, E., Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro. Oncogene 31 (2012), 2101–2114.
-
(2012)
Oncogene
, vol.31
, pp. 2101-2114
-
-
Noetzel, E.1
Rose, M.2
Bornemann, J.3
Gajewski, M.4
Knüchel, R.5
Dahl, E.6
-
25
-
-
34548570079
-
Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from silent to immunogenic
-
Obeid, M., Panaretakis, T., Tesniere, A., Joza, N., Tufi, R., Apetoh, L., Ghiringhelli, F., Zitvogel, L., Kroemer, G., Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from silent to immunogenic. Cancer Res. 67 (2007), 7941–7944.
-
(2007)
Cancer Res.
, vol.67
, pp. 7941-7944
-
-
Obeid, M.1
Panaretakis, T.2
Tesniere, A.3
Joza, N.4
Tufi, R.5
Apetoh, L.6
Ghiringhelli, F.7
Zitvogel, L.8
Kroemer, G.9
-
26
-
-
62049085194
-
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
-
Panaretakis, T., Kepp, O., Brockmeier, U., Tesniere, A., Bjorklund, A.-C., Chapman, D.C., Durchschlag, M., Joza, N., Pierron, G., van Endert, P., Yuan, J., Zitvogel, L., Madeo, F., Williams, D.B., Kroemer, G., Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J. 28 (2009), 578–590.
-
(2009)
EMBO J.
, vol.28
, pp. 578-590
-
-
Panaretakis, T.1
Kepp, O.2
Brockmeier, U.3
Tesniere, A.4
Bjorklund, A.-C.5
Chapman, D.C.6
Durchschlag, M.7
Joza, N.8
Pierron, G.9
van Endert, P.10
Yuan, J.11
Zitvogel, L.12
Madeo, F.13
Williams, D.B.14
Kroemer, G.15
-
28
-
-
0034614886
-
The induction of tolerance by dendritic cells that have captured apoptotic cells
-
Steinman, R.M., Turley, S., Mellman, I., Inaba, K., The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191 (2000), 411–416.
-
(2000)
J. Exp. Med.
, vol.191
, pp. 411-416
-
-
Steinman, R.M.1
Turley, S.2
Mellman, I.3
Inaba, K.4
-
29
-
-
77950829391
-
Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy
-
Takeshima, T., Chamoto, K., Wakita, D., Ohkuri, T., Togashi, Y., Shirato, H., Kitamura, H., Nishimura, T., Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res. 70 (2010), 2697–2706.
-
(2010)
Cancer Res.
, vol.70
, pp. 2697-2706
-
-
Takeshima, T.1
Chamoto, K.2
Wakita, D.3
Ohkuri, T.4
Togashi, Y.5
Shirato, H.6
Kitamura, H.7
Nishimura, T.8
-
30
-
-
79953209000
-
Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome
-
Wang, C.-I., Wang, C.-L., Wang, C.-W., Chen, C.-D., Wu, C.-C., Liang, Y., Tsai, Y.-H., Chang, Y.-S., Yu, J.-S., Yu, C.-J., Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Int. J. Cancer 128 (2011), 2364–2372.
-
(2011)
Int. J. Cancer
, vol.128
, pp. 2364-2372
-
-
Wang, C.-I.1
Wang, C.-L.2
Wang, C.-W.3
Chen, C.-D.4
Wu, C.-C.5
Liang, Y.6
Tsai, Y.-H.7
Chang, Y.-S.8
Yu, J.-S.9
Yu, C.-J.10
-
31
-
-
84926490613
-
Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer
-
Wang, C.-I., Wang, C.-L., Wu, Y.-C., Feng, H.-P., Liu, P.-J., Chang, Y.-S., Yu, J.-S., Yu, C.-J., Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer. J. Proteome Res. 14 (2015), 1739–1751.
-
(2015)
J. Proteome Res.
, vol.14
, pp. 1739-1751
-
-
Wang, C.-I.1
Wang, C.-L.2
Wu, Y.-C.3
Feng, H.-P.4
Liu, P.-J.5
Chang, Y.-S.6
Yu, J.-S.7
Yu, C.-J.8
-
32
-
-
33645739022
-
Gene expression profiling of primary cutaneous melanoma and clinical outcome
-
Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S.R., Avril, M.-F., Ortiz Romero, P.L., Robert, T., Balacescu, O., Eggermont, A.M.M., Lenoir, G., Sarasin, A., Tursz, T., van den Oord, J.J., Spatz, A., Melanoma Group of the European Organization for Research and Treatment of Cancer, Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl. Cancer Inst. 98 (2006), 472–482.
-
(2006)
J. Natl. Cancer Inst.
, vol.98
, pp. 472-482
-
-
Winnepenninckx, V.1
Lazar, V.2
Michiels, S.3
Dessen, P.4
Stas, M.5
Alonso, S.R.6
Avril, M.-F.7
Ortiz Romero, P.L.8
Robert, T.9
Balacescu, O.10
Eggermont, A.M.M.11
Lenoir, G.12
Sarasin, A.13
Tursz, T.14
van den Oord, J.J.15
Spatz, A.16
Melanoma Group of the European Organization for Research and Treatment of Cancer17
-
33
-
-
84873696767
-
Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets
-
Yamane, H., Paul, W.E., Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol. Rev. 252 (2013), 12–23.
-
(2013)
Immunol. Rev.
, vol.252
, pp. 12-23
-
-
Yamane, H.1
Paul, W.E.2
-
34
-
-
84880124478
-
Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment
-
Zeng, X., Yang, P., Chen, B., Jin, X., Liu, Y., Zhao, X., Liang, S., Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment. J. Proteom. 89 (2013), 51–70.
-
(2013)
J. Proteom.
, vol.89
, pp. 51-70
-
-
Zeng, X.1
Yang, P.2
Chen, B.3
Jin, X.4
Liu, Y.5
Zhao, X.6
Liang, S.7
-
35
-
-
62449215108
-
The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
-
van der Watt, P.J., Maske, C.P., Hendricks, D.T., Parker, M.I., Denny, L., Govender, D., Birrer, M.J., Leaner, V.D., The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int. J. Cancer 124 (2009), 1829–1840.
-
(2009)
Int. J. Cancer
, vol.124
, pp. 1829-1840
-
-
van der Watt, P.J.1
Maske, C.P.2
Hendricks, D.T.3
Parker, M.I.4
Denny, L.5
Govender, D.6
Birrer, M.J.7
Leaner, V.D.8
|